Your browser doesn't support javascript.
loading
A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
Droitcourt, Catherine; Rybojad, Michel; Porcher, Raphaël; Juillard, Caroline; Cosnes, Anne; Joly, Pascal; Lacour, Jean-Philippe; D'Incan, Michel; Dupin, Nicolas; Sassolas, Bruno; Misery, Laurent; Chevrant-Breton, Jacqueline; Lebrun-Vignes, Bénédicte; Desseaux, Kristell; Valeyre, Dominique; Revuz, Jean; Tazi, Abdellatif; Chosidow, Olivier; Dupuy, Alain.
Affiliation
  • Droitcourt C; Université de Rennes 1, Inserm CIC 1414, Rennes; Pharmacoepidemiology Unit, Inserm CIC 1414, Rennes.
  • Rybojad M; The Department of Dermatology, Hôpital Saint-Louis, AP-HP, Paris.
  • Porcher R; The Department of Biostatistics and Medical Informatics, Hôpital Saint-Louis, AP-HP, Paris; Université de Paris Diderot-Sorbonne Paris Cité, Paris; Inserm U717, Paris.
  • Juillard C; The Department of Dermatology, Hôpital Saint-Louis, AP-HP, Paris.
  • Cosnes A; UFR Medicine, Université de Brest, Brest.
  • Joly P; 11 chaussée de la Muette, Paris; Clinique Dermatologique.
  • Lacour JP; Inserm U905, Institute for Research and Innovation in Biomedicine (IRIB), Université de Rouen, Rouen; The Department of Dermatology, Hôpital Archet-2, CHU Nice, Nice.
  • D'Incan M; Université de Nice, Sophia Antipolis, Nice; The Department of Dermatology, Clermont-Ferrand.
  • Dupin N; The Department of Dermatology, Hôpital Cochin, AP-HP, Paris; Université René Descartes, Paris.
  • Sassolas B; CHU Estaing, and Université d'Auvergne Clermont-Ferrand.
  • Misery L; CHU Estaing, and Université d'Auvergne Clermont-Ferrand; The Department of Dermatology, CHRU Brest, Brest.
  • Chevrant-Breton J; The Department of Dermatology, CHU Rennes; Université de Rennes 1, Inserm CIC 1414, Rennes.
  • Lebrun-Vignes B; Pharmacovigilance Center, Groupe Hospitalier Pitié-Salpêtrière - Charles Foix, AP-HP, Paris.
  • Desseaux K; The Department of Biostatistics and Medical Informatics, Hôpital Saint-Louis, AP-HP, Paris; Université de Paris Diderot-Sorbonne Paris Cité, Paris; Inserm U717, Paris.
  • Valeyre D; The Department of Pneumology, Hôpital Avicenne, AP-HP, Bobigny.
  • Revuz J; Université Paris-Nord Bobigny, Paris.
  • Tazi A; The Department of Pneumology, Hôpital Saint-Louis, AP-HP, Paris; Université de Paris Diderot-Sorbonne Paris Cité, Paris.
  • Chosidow O; UFR Medicine, Université de Brest, Brest; The Department of Dermatology, Hôpital Henri-Mondor, AP-HP, Créteil; UPEC Université de Paris Est-Créteil Val-de-Marne, Créteil; French satellite of the Cochrane Skin Group and Centre d'Investigation Clinique 006-Inserm, Créteil, France.
  • Dupuy A; The Department of Dermatology, CHU Rennes; Université de Rennes 1, Inserm CIC 1414, Rennes; Pharmacoepidemiology Unit, Inserm CIC 1414, Rennes. Electronic address: alain.dupuy@chu-rennes.fr.
Chest ; 146(4): 1046-1054, 2014 Oct.
Article in En | MEDLINE | ID: mdl-24945194
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis / Skin Diseases / Thalidomide / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Chest Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoidosis / Skin Diseases / Thalidomide / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Chest Year: 2014 Document type: Article Country of publication: United States